RCL
57
-2
DUK
42
3
UAL
70
4
FMC
43
3
SYF
64
6
MAS
58
-10
AES
35
2
PG
45
2
PCG
81
4
EQR
56
2
D
32
-9
JBHT
35
12
FSLR
47
-5
INTC
43
-2
T
36
4
LEG
32
3
PCAR
56
-5
HCA
35
-5
VLO
30
-6
DD
48
2
RCL
57
-2
DUK
42
3
UAL
70
4
FMC
43
3
SYF
64
6
MAS
58
-10
AES
35
2
PG
45
2
PCG
81
4
EQR
56
2
D
32
-9
JBHT
35
12
FSLR
47
-5
INTC
43
-2
T
36
4
LEG
32
3
PCAR
56
-5
HCA
35
-5
VLO
30
-6
DD
48
2
Financhill
Back

Koninklijke Philips NV 10K Form

Buy
62

RYLPF
Koninklijke Philips NV

Last Price:
20.17
Seasonality Move:
0.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYLPF News And Ratings

See the #1 stock for the next 7 days that we like better than RYLPF

RYLPF Financial Statistics

Sales & Book Value

Annual Sales: $18.8B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

EPS (TTM): -2.46060
Net Income (TTM): $-2.18B
Gross Margin: $7.59B
Return on Equity: 0%
Return on Assets: 0%

Koninklijke Philips NV Earnings Forecast

Key Koninklijke Philips NV Financial Ratios

  • The Gross Profit Margin over the past 36 years for RYLPF is 40.35%.
  • The Selling, General & Administrative Expenses for RYLPF have been equal to 29.62% of Gross Profit Margin.
  • The Research & Development expenses have been 11.80% of Revenue.
  • The Interest Expense is -15.17% of Operating Income.
  • The Net Earning history of RYLPF is -9.02% of Total Revenues.
  • Per Share Earnings over the last 36 years have been positive in 22 years.

Koninklijke Philips NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: RYLPF
Website: philips.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYLPF Technical Analysis vs Fundamental Analysis

Buy
62
Koninklijke Philips NV (RYLPF) is a Buy

Is Koninklijke Philips NV a Buy or a Sell?